Quantcast

Latest Rome process Stories

2009-05-29 09:45:00

IBS Signs and Symptoms Tracker Sheds Light on IBS Warning Signs; IBS Treatment Matrix Helps Patients Find Relief BETHESDA, Md., May 29 /PRNewswire-USNewswire/ -- To mark World Digestive Health Day, the American College of Gastroenterology (ACG), in conjunction with global observances of this awareness day under the auspices of the World Gastroenterology Organisation (WGO), today announced the availability of two new interactive tools aimed at helping to provide answers and hope to millions...

2009-03-23 07:00:00

Study Adds to Growing Evidence of B. Infantis 35624 Efficacy in IBS Population CINCINNATI, March 23 /PRNewswire-FirstCall/ -- A review by researchers at Northwestern University (Chicago, IL) and University of Michigan (Ann Arbor, MI) of the utility of probiotics in the treatment of Irritable Bowel Syndrome (IBS) found that Bifidobacterium infantis 35624 was the only probiotic strain out of 13 different individual strains or preparations reviewed to significantly improve symptoms of IBS,...

2009-03-16 06:00:00

SAN DIEGO, March 16 /PRNewswire/ -- Prometheus Laboratories Inc., a specialty pharmaceutical and diagnostic company, announced today that it has received New York State approval for PROMETHEUS(R) IBS Diagnostic, the first and only blood test for irritable bowel syndrome (IBS). This novel test incorporates 10 biomarkers, two of which are proprietary, along with a proprietary algorithm to help physicians diagnose patients with IBS. "One out of five Americans has symptoms of IBS, however the...

2008-12-29 10:59:25

Chronic gastrointestinal symptoms are highly prevalent in different geographic populations and cause various gastrointestinal symptoms that greatly inconvenience the lives of those affected. Examples include GERD, uninvestigated dyspepsia, irritable bowel syndrome, and chronic constipation. These problems have an impact on the individual's quality of life. There is a lack of community-based research evaluating the impact of chronic gastrointestinal symptoms on the quality of life. A research...

2008-12-18 07:10:00

U-M experts helped develop new evidence-based recommendations put out today by the American College of Gastroenterology U-M Health Minute: Today's top health issues and medical research ANN ARBOR, Mich., Dec. 18 /PRNewswire-USNewswire/ -- Although irritable bowel syndrome (IBS) is the most common disease diagnosed by gastroenterologists, it's also one of the most misunderstood. That's why updated guidelines addressing the management of the condition are being released by the American...

2008-10-07 18:00:35

SAN DIEGO, Oct. 7 /PRNewswire/ -- Prometheus Laboratories Inc., a specialty pharmaceutical company, today announced findings from its development of PROMETHEUS(R) IBS Diagnostic, the first and only blood test for irritable bowel syndrome (IBS). The findings suggest measurable differences in the expression of particular biomarkers in blood samples between IBS and non-IBS patients. The identification of these biomarkers, combined with a proprietary algorithm, led to the development of...

2008-10-06 12:00:12

ORLANDO, Fla., Oct. 6 /PRNewswire/ -- Ironwood Pharmaceuticals (formerly Microbia) today announced presentation of data from a pair of preclinical studies delineating the role that cyclic guanosine monophosphate (cGMP) plays in alleviating intestinal pain. These studies demonstrate that cGMP inhibits intestinal pain in a preclinical model of intestinal hyperalgesia and desensitizes colonic afferent nerves in a similar model of experimental colitis. These results are from separate, ongoing...

2008-10-01 12:00:07

CAMBRIDGE, Mass., Oct. 1 /PRNewswire/ -- Ironwood Pharmaceuticals, Inc. today announced it has raised $50 million in a private equity financing. This capital will be utilized to support the ongoing Phase 3 development program evaluating linaclotide for the treatment of irritable bowel syndrome with constipation (IBS-C) and chronic constipation (CC), to invest in a growing pipeline of internally discovered drug candidates, and to expand commercial capabilities. The financing was led by Morgan...

2008-09-09 12:00:08

By PETER GOTT Dear Dr. Gott: I have suffered from Irritable Bowel Syndrome (diarrhea) for 50 years. It began in my early teens. I have tried everything from the early treatment of eating bland foods to today's adding bulk to my diet through the use of roughage and fiber. I still haven't found relief. Everything I do revolves around IBS, from school in my teens, to jobs, family activities and even everyday routines. I am now in my 60s, and retirement is hopefully not far away. I don't...

2008-05-18 18:00:05

SAN DIEGO, May 18 /PRNewswire/ -- New study results indicated that treatment with AMITIZA(R) (lubiprostone) 8 mcg lead to significant relief of overall symptoms of Irritable Bowel Syndrome with Constipation (IBS-C). These results were presented at Digestive Disease Week (DDW) 2008, the largest annual international meeting of digestive disease specialists. "IBS-C is a multi-symptom disorder and is one of the most common conditions seen by gastroenterologists," said William D. Chey, M.D.,...


Word of the Day
omphalos
  • The navel or umbilicus.
  • In Greek archaeology: A central boss, as on a shield, a bowl, etc.
  • A sacred stone in the temple of Apollo at Delphi, believed by the Greeks to mark the 'navel' or exact center-point of the earth.
'Omphalos' comes from the ancient Greek.
Related